People
Seth Lundy represents prominent medical device and pharmaceutical companies and healthcare providers, suppliers and distributors in complex legal and regulatory matters and investigations. As Deputy Chair of our FDA and Life Sciences practice, identified by Law360 as Life Sciences Group of the Year for 2016, Seth is widely recognized as a leading national authority on compliance with federal and state fraud and abuse laws. His practical, business-oriented approach earns accolades from sources including Chambers USA, Best Lawyers and Super Lawyers.
Seth's in-depth understanding of the industry allows him to work seamlessly with boards of directors, C-suite management, legal departments, compliance offices and operational divisions. He designs compliance programs; helps client to ensure that operations meet changing standards; defends clients in government investigations; performs internal audits; conducts corporate due diligence; and engages in civil, criminal and administrative litigation.
Seth is experienced in working with federal regulators and legislators to create, revise and interpret healthcare-related laws, regulations and policies. He also develops business and marketing strategies that respond to ever-changing federal regulatory schemes.
A frequent author and speaker on healthcare compliance and investigations, Seth works to help clients to identify and predict burgeoning areas of enforcement. Seth has been recognized since 2008 as a top Washington, D.C. healthcare lawyer by Chambers USA. He has also received recognition as a leading healthcare lawyer from Expert Guides, Guide to the Leading Healthcare Lawyers, Super Lawyers Washington, D.C., Best Lawyers, and Washingtonian Magazine's Top Lawyers rankings.
J.D., George Washington University, with honors
B.A., Amherst College, cum laude
District of Columbia
Maryland
French
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
February 18, 2022
Chambers Global 2022 Recognizes King & Spalding as a Leading International Law Firm
April 25, 2022
COVID-19 Health Care Fraud Enforcement on the Rise: What’s Ahead for the Life Sciences & Healthcare Industries
March 28, 2022
AdvaMed Updates Code of Ethics on Interactions with HCPs: What’s the Impact on MedTech?
March 21, 2022
Chambers Global Practice Guide: Pharmaceutical Advertising 2022
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
February 18, 2022
Chambers Global 2022 Recognizes King & Spalding as a Leading International Law Firm
April 25, 2022
COVID-19 Health Care Fraud Enforcement on the Rise: What’s Ahead for the Life Sciences & Healthcare Industries
March 28, 2022
AdvaMed Updates Code of Ethics on Interactions with HCPs: What’s the Impact on MedTech?
March 21, 2022
Chambers Global Practice Guide: Pharmaceutical Advertising 2022
June 8, 2022
Legal 500 United States 2022 Recognizes King & Spalding Practices and Lawyers Among the Top in the Nation
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
February 18, 2022
Chambers Global 2022 Recognizes King & Spalding as a Leading International Law Firm
J.D., George Washington University, with honors
B.A., Amherst College, cum laude
District of Columbia
Maryland
French